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Available online 21 October 2016Background: Hip fractures are mainly caused by accidental falls and trips, which magnify forces in well-defined
areas of the proximal femur. Unfortunately, the same areas are at risk of rapid bone loss with ageing, since
they are relatively stress-shielded during walking and sitting. Focal osteoporosis in those areas may contribute
to fracture, and targeted 3D measurements might enhance hip fracture prediction. In the FEMCO case-control
clinical study, Cortical Bone Mapping (CBM) was applied to clinical computed tomography (CT) scans to define
3D cortical and trabecular bone defects in patients with acute hip fracture compared to controls. Direct measure-
ments of trabecular bone volume were then made in biopsies of target regions removed at operation.
Methods: The sample consisted of CT scans from 313 female and 40 male volunteers (158 with proximal femoral
fracture, 145 age-matched controls and 50 fallers without hip fracture). Detailed Cortical Bone Maps (c.5580
measurement points on the unfractured hip) were created before registering each hip to an average femur
shape to facilitate statistical parametric mapping (SPM). Areas where cortical and trabecular bone differed
from controls were visualised in 3D for location, magnitude and statistical significance. Measures from the
novel regions created by the SPM process were then tested for their ability to classify fracture versus control
by comparison with traditional CT measures of areal Bone Mineral Density (aBMD). In women we used the sur-
gical classification of fracture location (‘femoral neck’ or ‘trochanteric’) to discover whether focal osteoporosis
was specific to fracture type. To explore whether the focal areas were osteoporotic by histological criteria, we
used micro CT to measure trabecular bone parameters in targeted biopsies taken from the femoral heads of 14
cases.
Results: Hip fracture patients had distinct patterns of focal osteoporosis that determined fracture type, and CBM
measures classified fracture type better than aBMD parameters. CBM measures however improved only mini-
mally on aBMD for predicting any hip fracture and depended on the inclusion of trabecular bonemeasures along-
side cortical regions. Focal osteoporosis was confirmed on biopsy as reduced sub-cortical trabecular bone
volume.
Conclusion: Using 3D imaging methods and targeted bone biopsy, we discovered focal osteoporosis affecting tra-
becular and cortical bone of the proximal femur, among men and women with hip fracture.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Osteoporosis
Pathogenesis
Hip fracture
Fracture prediction1. Introduction
Hip fractures are the most common reason for orthopaedic hospital
admission in older people [1,2], accounting for N85,000 admissions.
. This is an open access article underannually in the UK [3] and causing considerable mortality [4]. N90% of
all hip fractures in the elderly are sustained through a fall, although
some involve less trauma, happening spontaneously or during trips
and stumbles [1]. Fracture occurs when mechanical strain is dispropor-
tionately concentrated on one part of the bone compared to surround-
ing regions [5]. The forces that act on a femur during floor-impact or
during a stumble can be replicated in the laboratory. These simulations
indicate that hip fractures initiate in small highly consistent focalthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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often become thin and porous through decades of age-associated bone
loss, since they are stress-shielded during activities such as walking
[8]. Micro CT measurements of trabecular bone from femoral head and
neck biopsies support this notion, with substantially more bone present
in areas directly loaded by walking than in fracture-prone zones [9,10].
Ordinary clinical computed tomography (CT) scans have been be
used to identify focal 3D bone loss in ageing and as a predictor of frac-
ture [11–16]. Cortical BoneMapping (CBM) couples CT imaging capabil-
ity with an evaluation method to find average differences between
groups known as statistical parametric mapping (SPM) [11–16]. CBM
can also be used to visualise femoral cortical thickness in CT scans
from individual patients (Fig. 1).
By studying the intact contralateral femur of women with hip frac-
ture from the Czech Republic (taking advantage of the anatomical sim-
ilarity with the fractured side) we previously used CBM to discover
thumbnail-sized patches of cortical thinning in fracture-prone focal re-
gions [17]. Next we applied CBM to baseline scans from a case-cohort
study of 288 healthy older male volunteers from the prospective MrOS
study. Comparing the 99 men from the cohort who went on to sustain
hip fractures with their fracture-free counterparts, we identified focal
osteoporosis (focal regions of thin cortical bone [17] along with larger
trabecular defects [18]) that predicted fracture (femoral neck, FN or tro-
chanteric, TR Fig. 1a) slightly better than did two-dimensional areal
bone mineral density (aBMD) measurements from Dual Energy X-ray
Absorptiometry (DXA). Not only are the two hip fracture types known
to originate at anatomically distinct foci (Fig. 1) [19] but from a surgical
perspective aremanaged differently. Even though the overall prediction
of hip fractures using CBM and DXA was similar [20], identifying focal
osteoporosis through imaging techniques such as CBM might help in
the proactive prevention of hip fracture given that targeted implanta-
tion of locally acting pharmaceuticals via the greater trochanter is tech-
nically feasible [21]. Traditional QCTmeasures of femoral neck and ‘total
hip’ areal BoneMineral Density (for example CTXA™, Mindways Austin,
Texas, USA [22]) are now in routine clinical usage for hip fracture pre-
diction by incorporation in the WHO FRAX™ tool. Several important
questions remain; i) is focal osteoporosis present in the cortical
and trabecular bone of women with hip fracture, and ii) do the
CBM measures discriminate hip fractures better than traditional
QCTmeasures of femoral neck and ‘total hip’ density (Fig. 1b)? To an-
swer these questions we analysed data from several case-control
studies, involving participants from both sexes who had sustained
the two commonest types of hip fracture. We applied CBM [13,14,
23] to clinical CT scans from the intact hip of cases and controls to de-
fine the 3D regions of interest (ROIs) where cortical and trabecular
bone defects are associated with hip fracture, and then compared
CBM with CTXA measures using Receiver Operator Characteristic
analysis (ROC). Having identified defects, we then took targetedFig. 1. a) Boundaries for classifying the two main types of hip fracture; femoral neck (FN) and t
Standard clinical two-dimensional areal bone mineral density (aBMD) measurements of i) t
measurement used in this study (QCTpro CTXA version 5.1.3, Mindways Software Inc., Austin,core biopsies from those regions at hemi-arthroplasty for accurate
assessment of trabecular bone volume.
2. Materials and methods
2.1. FEMCO study; ethics and overview
The FEMCO study (Table 1) commenced in 2007, recruiting partici-
pants from Cambridge (LREC 07/H0305/61). Clinical CBM and CTXA
measurements were made on the intact hip of fracture-patients
scanned in an acute setting before surgical repair. After formal protocol
amendments, the FEMCO studywas adopted onto theUKNational Insti-
tute for Health Research (NIHR) portfolio and several other centres con-
tributed participants after informed consent (http://public.ukcrn.org.
uk/search/StudyDetail.aspx?StudyID=5290). The study protocol, CT
imaging parameters and recruitment were closely aligned with previ-
ous Cambridge studies (MRC-Hip Fx, MRC-Ageing LREC 06/Q0108/
180, LREC99/076 and Anglo-Cardiff Collaborative Trial, ACC LREC 04/
Q0108/257) as well as Prague studies (Study of Hip Joint in Trauma,
IRB0002384101) [24]. All hip fractures were classified by the Muller
AO criteria by a consultant radiologist (TDT) into femoral neck, FN
(trans-cervical AO31-B1, B3 and sub-capital AO31-B2), or trochanteric,
TR, types frommulti-planar reformatted CT images. We combined frac-
ture and control participants from all our studies in the present analysis.
The key protocol details, including selection criteria for the FEMCO,
MRC, ACC and Prague studies, are listed in Tables 1–5.
2.2. Subjects and specimens
1 Femoral clinical CT scans from cohorts of patients; combined case-
control studies
1.1 Hip fracture patients (n = 70, 50 Female, 20 Male) versus 70
healthy gender matched controls
1.2 Hip fracture patients (n= 138, Female) grouped by hip fracture
type (52 Trochanteric, 86 Femoral Neck) versus healthy age and
gender matched controls (n= 125)
1.3 Frail patients with at least one injurious fall (n= 50) versus 50
healthy age and gender matched controls
2 Micro CT in hip fracture specimens
2.1 FN hip fracture operative specimens (n= 14)
2.3. Description of studies
2.3.1. Study 1.1
This case-control study used CBM and SPM to identify differences in
bone parameters (cortical mass surface density CMSD and endocorticalrochanteric (TR), shown on a 3D Bone Map of cortical thickness from a clinical CT scan b)
he total hip region and ii) the femoral neck region. Approximate boundaries for aBMD
Texas).
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(50F, 20M) and 70 gender-matched healthy controls from previous
Cambridge studies [24,25]. Our aim was to determine if the focal osteo-
porosis that we had identified in hip fracture patients from the Czech
Republic [17] was present in an independent population.
2.3.2. Study 1.2
This case-control study used CBM and SPM after combining women
with hip fracture fromFEMCOand Prague studies (n=138, 52 Trochan-
teric and 86 Femoral Neck byMuller AO classification [26]) and compar-
ing their bone parameters with those from 125 healthy age-matched
female controls from previous Cambridge and Prague studies. Our aim
was to determine if patches of focal osteoporosis differed between frac-
ture types (TR or FN). A further aim was to determine how well CBM
measures (CMSD and ECTD) with or without areal bone density mea-
surements (CTXA) discriminated hip fractures from controls with Re-
ceiver Operating Characteristics (ROC) analysis. Protocol amendments
were made to both FEMCO and the associated Prague Hip Joint in Trau-
ma studies [17] to align selection and CT scanning criteria aiming to
combine patients from both centres. This gave sufficient numbers of
hip fracture cases and controls from each country to allow us to study
differences between FN and TR fracture in women.
2.3.3. Study 1.3
This case-control study used CBM and SPM to identify differences in
bone parameters between 50 FEMCO female hospitalised fallers and 50
age-matched healthy female controls from previous Cambridge studies.
Our aimwas to determine if focal osteoporosiswas present in fall-prone
elderly women. Fallers were defined as having had a recent admission
to an ortho/geriatric unit following a fall, with or without any fracture
(except hip fracture), from a standing height or less.
2.3.4. Study 2.1
This observational study involved targeted evaluation of the trabec-
ular bone microstructure in the femoral head-neck junction (informed
by the above studies) and another unloaded part of the femoral head,
conducted at micro-CT resolution in 14 surgical specimens from
FEMCO FN hip fracture patients. Our aimwas to determine if focal oste-
oporosis could be identified by Bone Volume/Tissue Volume (BV/TV)
measurement in affected areas.
2.4. Bone measurements; estimating cortical mass surface density and tra-
becular density from CT data
The analysis of local cortical parameters, such as thickness or cortical
mass surface density, has historically been limited since thin structures
such as the femoral cortex are not accurately depicted in clinical CT due
to the limited spatial resolution of the images. Recent developments
allow the estimation of local cortical and trabecular parameters from
CT images. In this, as in previous studies, estimations were made at
thousands of locations (‘vertices’) on a surface mesh of the unfractured
proximal femur [13,14]. Themeshwas created by segmentation of fem-
oral bone from surrounding tissues using Stradwin (v5.1 available free
to download at http://mi.eng.cam.ac.uk/~rwp/stradwin). Also using
Stradwin, the CT data was sampled at each vertex of the mesh using
18 mm lines perpendicular to and passing through the femoral cortex
and trabeculae as described in detail recently [27]. Previously, we have
used restrictive models of both the femur being scanned and the imag-
ing system and then fitted these models to the observed data. Since a
dense, thin, blurred cortex might appear identical to a less dense,
thicker, blurred cortex with such an approach, we therefore needed to
incorporate some prior knowledge about either the density or the
blur; finding that assuming a specific, fixed value for the density was
more successful than assuming a constant blur [14]. Later, we described
a robust method for estimating this density, and extended the analysis
to include cortical mass surface density which is the product of corticalthickness and cortical density (CMSDmg/cm2) as well as cortical thick-
ness (CTh) [13].We chose CMSD for the current analysis since it was re-
cently found to be the most accurate and precise of the measures from
cortical bone mapping [23]. Recognising the importance of trabecular
bone measures in fracture discrimination, we also estimated
endocortical trabecular density (ECTD,mg/cm3) by taking the calibrated
height of that part of the 18 mm line passing through the trabecular
bone. The process of registering femurs to a canonical (‘average’) sur-
face yielded data on shape and bone size. Most (81%) of the variation
in shape between femurs can be explained by a small number of defor-
mation modes (as Whitmarsh et al. found [28,29]). We therefore
summarised each individual's shape as a 5-element vector representing
the deformation of the femur along each of the 5 principal modes. The
first mode could be described as overall femur size and the second ap-
proximates to femoral neck axis length. This 5-element shape vector
was used in subsequent SPM. To measure aBMD, Mindways QCTpro
CTXA (version 5.1.3, Mindways Software Inc., Austin, Texas) was used
to give measures of femoral neck (Fn) or total hip (Th) aBMD in g/cm2
(as utilised in the current version of the WHO FRAX tool).
2.5. Statistical analysis models for SPM
Demographic variables were compared and expressed as mean and
standard deviationwith Student's t-test to determine the significance of
any differences between cases and control (JMP v11, SAS institute). Sta-
tistical analysis of the registered femurs was performed using SPM [30]
as implemented in the SurfStat package [31]. SPM involvedfitting a gen-
eralised linear model to determine CMSD (or ECTD) in terms of explan-
atory and confounding variables. The model coefficients were then
examined to reveal how the data depended on each covariate to identify
where on the femur, if anywhere, each covariate was predictive of
thickness or mass (with an associated p-value). Central to successful in-
ference using SPM was the question of which covariates to include in
the model. The null hypothesis was that there would be no focal differ-
ences in CTh, CMSD or ECTD between fracture and controls in 3D
femoral structure. Therefore the fixed effects generalised linear SPM
model (GLM) used for Study 1.1 was CMSD (or ECTD) =
1 + group + age + weight + sex + shape 2 + shape 3 + shape
4 + shape 5. The same GLM, but substituting site (Czech Republic or
UK) for sex was used for Study 1.2. Group was defined as ‘fracture or
control’ in Study 1.1, ‘FN fracture, TR fracture or control’ in Study 1.2
and ‘faller or control’ in 1.3. In these models, age and weight, site and
shape modes 2–5 were modelled as confounding variables. Allowing
for shape (parameterized using the discrete shape modes derived
from the registration process) guarded against false inference caused
by systematic misregistration [32]. We did not model shape mode 1
(femur size) or patient height, since these covariates were correlated
with group and we would have encountered the well-known problem
of correlated regressors. Consequentially, we would have been in dan-
ger of missing significant effects [31] because the statistical tests in
SPM reveal only the variance that can be ascribed uniquely to the covar-
iate(s) of interest [33,34]. The only imaging-derived explanatory vari-
ables were the shape modes, and there was no justifiable reason to
expect these to differ with study (and certainly not with scanner/phan-
tom type), so group was not nested within ‘study’ in 1.2.
2.6. Creation of a region of interest (ROI) for discriminatory analysis (Re-
ceiver Operating Characteristics)
Single averagemeasurements across the entire ROI (generated from
the completed process of SPM for each patient in Study 1.2) were then
derived. In the present study, therewere four ROIs: a ‘femoral neck frac-
ture cortical’ and a ‘trochanteric fracture cortical’ ROI as well as a ‘fem-
oral neck fracture trabecular’ and ‘trochanteric fracture trabecular’ ROI
(for ROI boundaries, see Fig. 3c–f). These single ‘patch average’ values
were then taken forward (along with demographics) to test the
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rectly classify fracture versus control and also TR and FN types. CBMwas
compared with CTXA. Receiver Operating Characteristics (ROCs) were
created using leave-one-out cross-validation, such that predictions for
each subject were only ever made on ROIs and models not containing
that subject. Individual odds ratios for each ROI, as well as for CTXA
values, were calculated separately from multinomial regression.
2.7. Precision measurements
Precision was previously assessed in repeat analysis of 19 individ-
uals re-imaged with CT and re-analysed after an average of 61 days
(standard deviation 22 days, range 34 to 107 days) giving a measure-
ment precision of 5% of the mean at individual measurement points,
dropping to 1% of the mean when measurements were averaged over
a defined region of interest.
2.8. Bone measurements: femoral head surgical specimen selection and
preparation
Femoral heads were obtained from 14 FEMCO participants who had
undergone CT scanning prior to surgery. Once each femoral head had
been removed at arthroplasty it was placed in 70% ethanol for at least
7 days for fixation. Femoral heads were sawn in half to make taking
the cores easier. A modified Bordier trephine (diameter 7 mm) was
used to take core biopsies from each half, one from the ROI in the an-
terolateral femoral head known to be associated with FN fracture [17]
and the other from the subfoveal region on the opposite side of the
head for comparison (Fig. 2).
Each biopsy was placed cortex down in a Perspex mould and
scanned in air in a Metris X-TEK HMX CT 160 microCT scanner (Nikon
Metrology, Derby, UK) at 50 kV and 60 μA, FOV 1024 × 1024 pixels, ac-
quisition time c. 1 h. Images were centred and squared in XTEK – NGI
control software then images were further straightened in CT PRO soft-
ware (supplied with the scanner). VGStudio max software (Volume
Graphics GmbH, Heidelberg, Germany) was used to create DICOM im-
ages (voxel size 0.02 × 0.02 × 0.02 mm). ImageJ N Bone J (http://
imagej.nih.gov/ij/) was used to open the DICOM data (orientated per-
pendicularly to the long axis of the cylindrical biopsy, Fig. 2, lower
pane) [35]. Images containing just the trabecular portion of the biopsy
were then selected. The middle image of this stack was chosen as a ref-
erence point for each core for automatic brightness and contrast adjust-
ment. On that same image a circular ROI was created (6.26mm) leaving
a smallmargin at the periphery of the core. The imageswere segmented
into bone and background and an automatic measurement of bone vol-
ume/tissue volume (BV/TV) was taken using the method described by
Doube [35] to give an overall BV/TV for the core. Using the ‘delete slice
range’ option from the ‘stacks’ sub option of the ‘plugins’ menu BV/TVFig. 2. Biopsy regions. The cartoon shows the locations for the biopsies, and a resulting XTEK hi
donated their femoral head at operation. Also shown are the five 100-slice segments.measurements were then averaged throughout the core in 100 slice
stacks (2.3 mm) to determine BV/TV through the length of the biopsy
from the subcortical part to the trabecular end of the biopsy (Fig. 2).
This method involved reloading the stack of images before cutting it
down to measure each 100-slice stack. Thus, internal quality control
was provided as the whole biopsy BV/TV was measured each time and
the coefficient of variation of the overall biopsy BV/TV ranged in individ-
ual cases from 0 to 0.76%. BV/TV data was complete for all cores for the
first three hundred slices; after that point due to damage to the cores
(caused by either the femoral head extraction process or crushing dur-
ing the biopsy extraction process) the data were less complete so that
only the first 500 slices (11.5 mm) could reasonably be compared.
Paired t-tests were performed comparing each stack of 100 images be-
tween the two biopsy sites.
3. Results
3.1. Study 1.1
Comparison of 70 hip fracture patients (20male and 50 female)with
70 healthy gender-matched controls: Fig. 3a and b show colour maps of
the statistically significant differences between hip fracture patients and
healthy controls in cortical mass surface density (CMSD, the primary
outcomemeasure) and trabecular bone (ECTD). The focal differences in-
volved several ROIs including the supero-anterior and inferior femoral
neck. The hip fracture cases were statistically significantly older (cases
mean age 78.3 yrs ±9.9 standard deviation; healthy controls 74.0 ±
9.1, p= 0.0084), lighter (cases weight, 62.6 ± 12.5 kg; healthy control
70.9 ± 13.5, p = 0.0002) and had lower aBMD (cases femoral neck
aBMD, 0.53 ± 0.11 mg/cm2, healthy control 0.70 ± 0.13, p b 0.0001).
They were only well matched for height (cases height, 1.65 ± 0.09 m;
healthy controls 1.64 ± 0.10, p = 0.74). There were 51 FN fractures,
but only 19 TR fractures, hence the need to combine these subjects
with the Prague Study of Hip Fracture participants (Study 1.2).
3.2. Study 1.2
Comparison of hip fracture type (FN, n = 86 or TR, n = 52) with
healthy age and gender matched controls (all female, n = 125): The
main findingwas the strikingly focal, rather than generalised, difference
in cortical and trabecular bone between controls and fracture cases (Fig.
3c–f). FN fracture types had a focal cortical bone defect that
encompassed the superior femoral head neck junction and passed
around the inferior neck and towards the anterior part of the trochanter.
TR fractures also had a marked cortical bone defect in the trochanter it-
self. There was at least 20% less cortical bone in the ‘core’ of the ROI,
compared with controls. Fig. 3d also shows a matching focal trabecular
bone defect in FN fracture cases (similar to the cortical regions) and thisgh resolution scan image through the femoral head of a FEMCO study participant who had
Fig. 3. Study 1.1. Bone Mapping (CBM) ROIs. Statistically significant differences in cortical (a) and trabecular (b) bone between hip fracture (n= 70, 50 female, 20 male) and 70 healthy
controls shown as a colour map on the canonical femur model. CMSD Cortical Mass Surface Density, ECTD Endocortical Trabecular Density Study 1.2. Cortical (c) and trabecular (d)
differences between female femoral neck patients (n= 86) and controls (n= 125). Cortical (e) and trabecular (f) differences between female trochanteric fracture patients (n= 52)
and controls (n = 125). The black arrow highlights the biopsy site for Study 2.1. Study 1.3. Cortical (g) differences between frail female patients with at least one injurious fall (n =
50) versus 50 healthy controls (no difference in trabecular bone (h)).
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olution microCT in Study 2.1 (shown by a black arrow). There was a
more generalised trabecular bone deficit in TR fracture cases. Trabecular
bone loss affectedmore of the femur than cortical bone loss in both frac-
ture types. For femoral neck fractures, considering the total bone surface
measured, 35.4% of trabecular and 18% of cortical measurements were
statistically significantly lower than control. 22% of the areas with tra-
becular defects had corresponding cortical defects. For trochanteric frac-
tures, on average 82.1% of trabecular and 48.9% of cortical
measurements were lower than control. 36.9% of areas with trabeculardefects had corresponding cortical defects. The combined UK and
Czech female hip fracture cases were statistically significantly lighter
(cases weight, 0.59 ± 0.13 kg; 63.2 ± 11.5 healthy control 66.4 ±
11.2, p = 0.024), taller (cases height, 1.62 ± 0.07 m; healthy controls
1.58 ± 0.07, p b 0.0001) and had lower femoral neck CTXA aBMD
(cases aBMD, 0.59 ± 0.13 mg/cm2; healthy control 0.69 ± 0.12,
p b 0.0001). They were well matched for age (cases age, 77.4 ±
8.7 yrs; healthy controls 76.8 ± 7.3, p = 0.56). FN cases and TR cases
had similar femoral neck aBMD (FN fracture aBMD, 0.59 ±
0.13 mg/cm2; TR 0.60 ± 0.12, p = 0.53), age (FN age, 77.1 ± 8.8 yrs;
129K.E.S. Poole et al. / Bone 94 (2017) 124–134TR 77.4 ± 8.9, p = 0.89) and weight (FN weight, 62.6 ± 10.2 kg; TR
63.6 ± 13.1, p = 0.61). Women with bigger femurs (larger shape
mode 1)weremore likely to have sustained hip fractures (FN difference
in shape mode 1 v control +0.77 ± 0.32, p b 0.0001, TR +0.50 ± 0.31,
p = 0.002). There were no differences between hip fracture and con-
trols in any of the other shape parameters (p values ranged from 0.23
to 0.75).3.3. Study 1.3
Comparison of 50 frail females who had fallen with 50 healthy age
and gender-matched controls: Fig. 3g shows a statistically significant
difference between UK FEMCO fallers and healthy controls in CMSD.
The fallers had lower CMSD than controls in ROIs that were smaller,
but in similar anatomical locations to those observed in the hip fracture
cases (Study 1.1). Although this suggests that cortical bone defects are
also present in frail fall-prone elderlywomen, therewere no statistically
significant differences in trabecular density (ECTD, Fig. 3h).
This result confirms that inpatient fallers are a potentially unsuitable
control group for studies involving hip fracture patients, due to ascer-
tainment (Berkson's) bias [36]. The female fallers were well matched
to controls for age (fallers age, 75.5 ± 8.6 yrs.; healthy controls
77.3 ± 7.5, p = 0.28), weight (fallers weight, 69.1 ± 16.0 kg; healthy
control 67.1 ± 12.1, p = 0.48) and height (fallers height, 1.61 ±
0.07 m; healthy controls 1.60 ± 0.07, p=0.34). The fallers had statisti-
cally significantly lower femoral neck aBMD (fallers aBMD, 0.59 ±
0.13 mg/cm2; healthy control 0.65 ± 0.09, p= 0.0096).3.4. Study 2.1
Femoral neck hip fracture operative specimens: There was statisti-
cally significantly less sub-cortical trabecular bone volume (BV/TV) in
the targeted biopsy taken from the ROI identified in Fig. 3d compared
with the inferior subfoveal core (see Fig. 4). The surgical specimens
came from individuals who represented the overall UK FEMCO sample
well for age (biopsy patients age, 78.0 ± 8.5 yrs; all FEMCO hip fracture
patients 78.6 ± 9.7, p = 0.57), height (biopsy patients height, 1.65 ±
0.10 m; all FEMCO 1.63 ± 0.09, p= 0.48) and weight (biopsy patients
weight, 65.4 ± 17.7 kg; all FEMCO 61.3 ± 11.8, p = 0.47). The biopsy
patients had similar femoral neck aBMD to the rest of the FEMCO
cases (biopsy patients aBMD, 0.57 ± 0.12 mg/cm2; all FEMCO 0.52 ±
0.11, p b 0.07), and it is also noteworthy that their average T-score
was not in the osteoporotic range –2.02 (±1.04). Examining paired
samples, the only significant difference was in the sub-cortical region
of the cores (p = 0.046) beyond that point there were no significant
differences.Fig. 4. Results from biopsy study. The graph shows the statistically significantly lower BV/
TV (with standard error of the mean) in the trabecular area highlighted by the Bone
Mapping technique (black arrow in Fig. 3d). p = 0.046 for the paired difference
between 1 and 100 slices.3.5. Receiver operating characteristic (ROC) curves for fracture
determination
The results described in Study 1.2 led us to test individual parame-
ters and combinations of parameters in sensitivity analyses. We calcu-
lated a single average cortical measurement from each patient
incorporating values across all significant bone mapping ROIs shown
in Fig. 3(c–f), repeating that process for trabecular bone ROIs.We calcu-
lated the Area Under the Curve (AUC) from Receiver Operating Charac-
teristic (ROC) analysis to compare fracture discrimination using bone
mapping (cortical, trabecular or both) values with aBMD of the femoral
neck (Fn) and total hip (Th) regions. It can be seen from Fig. 5a, that Fn
and Th aBMD together are good at discriminating all fractures from con-
trol subjects (AUC 0.79). aBMD is somewhat less effective at determin-
ing fracture type (dotted and dashed grey lines). Bone mapping
measurements from cortical ROIs alone did not increase the AUC for dis-
criminating fractures from controls (Fig. 5b). It was only after adding
values from the trabecular ROIs that the AUC improved to be numerical-
ly greater than aBMD (AUC 0.82, Fig. 5c and d), with improved deviance
statistics. While individual adjusted odds ratios do not quantify classifi-
cation accuracy, we did find that odds ratios from multinomial regres-
sion were numerically greater for trabecular bone measures than they
were for cortical bone measures (Table 6).
4. Discussion
Femoral neck and trochanteric fracture patients had different pat-
terns of focal osteoporosis. Such focal osteoporosis is unfortunate,
since it affects locations in the proximal femur where cracks are expect-
ed to initiate during falls (at least as simulated in the laboratory [6,5]).
Trabecular bone loss affected more of the femur than cortical bone
loss in both fracture types. As reflected in ROC analysis and odds ratios
the ability to effectively discriminate hip fractures from controls was
better when including trabecular (as well as cortical) measurements.
In our study, womenwith femoral neck fractures had large focal defects
located within the superior neck, particularly at the head-neck junction
(Fig. 3c–d), compared with controls. Women with trochanteric frac-
tures lacked trabecular bone throughout the femur (except in the load-
ed inferior cortex), but also lacked cortical bone in a focal patch that
incorporated both the lateral trochanter and superior femoral neck
(Fig. 3e–f). In ROC analysis, CBM measures improved upon CTXA mea-
sures for discriminating fracture type from controls (from 0.79 with
CTXA to 0.82 with CBM), but crucially, this was only when trabecular
bone was included in the model. This adds considerable support to
data indicating that trabecular bone is an important determinant of
hip fracture [37–40]. Deficient trabecular bone in the hip [41–43] has
been implicated in increased fracture risk due to anisotropy leading to
inability to copewith loading from an unexpected direction as in a side-
ways fall [44]. Since cortical thinning reduces the hip's capacity to ab-
sorb energy imparted by a fall [7], it follows that trabecular bone loss
adds to this effect. By directly sampling the areas identified as most de-
ficient by imaging (Fig. 3d, black arrow), our MicroCT findings confirm
focal osteoporosis (“too little bone in the bone” [45]). The biopsied pa-
tients did not have generalised osteoporosis as evidenced by their
aBMD T-scores, which underlines the focal nature of the bone volume
defect found.
DXA scanning for fracture risk estimation is unlikely to be surpassed
by higher radiation CT technology in routine clinical practice, but the
present study is useful in confirming the clinical utility of both CTXA
and CBMmeasurements. Our findings fit well with thework of Duboeuf
and co-workers using the EPIDOS prospective cohort [46]. They found
that measuring the upper half of the femoral neck with DXA enhanced
the prediction of FN hip fracture, while aBMD of the lower half was no
different from controls [46]. Alongside recent evidence that osteoporo-
sis treatments and exercise have focal effects on the proximal femoral
cortex and trabeculae [27,47,48], our CBM results suggest that hip
Fig. 5. a) Area Under the Curve (AUC) from Receiver Operating Characteristic analysis for the ability of age, height, Femoral neck (Fn) and Total Hip (Th) DXA-like areal Bone Mineral
Density (aBMD) from CT to correctly categorise hip fracture types (grey lines- dotted for TR or dashed for FN) as well as all hip fractures (black solid lines-ALL HIP FX). ROC analysis
for different combinations of the novel 3D Cortical Bone Mapping (CBM) measures to correctly discriminate hip fractures (5b–d). An average single measure of 3D Cortical Mass
Surface Density or Trabecular Density (ECTD) was taken for each patient from the bone mapping ROIs (shown as patches in Fig. 3c–f). The ability of age, height and an average 3D
measure of either CMSD (5b), ECTD (5c) or both CMSD and ECTD (5d) to correctly discriminate fractures, as well as the corresponding AUC values and 95% confidence intervals for
discriminating all fractures (ALL FX), Trochanteric fractures (TR) and Femoral neck (FN) are shown.
130 K.E.S. Poole et al. / Bone 94 (2017) 124–134fracture prevention strategies may need to be tailored to improve the
focal femoral defects which are characteristic of each fracture type.
There is increased interest in the assessment of CT variables in at-
risk patientswho are undergoing clinical CT for other diagnostic reasons
[49]. CT is also useful for estimatingwhole bone strength under different
simulated loading conditions. Finite element models based on CT data
are approved for the clinical prediction of hip fracture and drugs have
been shown to strengthen the bone under simulated loading conditions
[50,51]. Several recent studies have used either traditional ROI analyses
to investigate the influence of CT cortical bonemeasures on hip fracture
risk [40,52,53] or derived novel ROIs using the aforementioned SPM
techniques [11,39,54] to find 3D bonemineral density patterns associat-
edwith hip fracture. All of these have found associations between 3DCT
measures and fracture, and our analysis fits well alongside the voxel-
based morphometry work of Carballido-Gamio et al. [53]. However,
the greater number of fractures of each type (FN and TR) that we had
available allowed us to investigate fracture-type specific ROIs.
Johannesdottir et al. examined femoral neck cortical thickness in the
Icelandic AGES Reykjavik study before Carballido-Gamio et al., but
using Mindways CTXA BIT2 software. In that study, the main finding
was that supero-anterior femoral neck cortical thickness was strongly
related to fracture, especially FN fracture, and remained a significant
predictor of hip fracture even after allowing for femoral neck aBMD
(also allowing for age, weight and height) [40]. Bousson et al. examined
the distribution of CT-derived 3D BMDmeasures for classifying fracture
type. Their results suggested that the volume of cortical bone in the tro-
chanter was the main difference between fracture types (TR and FN) -
similar to our findings. In addition, they found that the BMD of the fem-
oral head was a strong predictor of fracture status [39]. With a similar
study design to ours, the sensitivity analyses of Bousson are broadly in
agreement with our own. Our results, however, pinpoint and quantify
precisely where one should look in the 3D structure of the hip as a
whole.
The FEMCO protocol also permitted comparison between patients
with hip fracture and fallers without hip fracture. Fallers were often
frail, and had sustained trauma or even peripheral fractures of one
type or another. It was perhaps not surprising (with hindsight) that
there were no systemic differences between the hip fracture patients
and fallers. Elderly fallers did have focal bone defects in their hips
when compared to healthy controls (Fig. 3g) and their future hip frac-
ture risk is presumed to be substantial.
Our study has limitations. Combining analyses of healthy volunteers
from several cohorts is a convenience analysis, and neither the samplingof the cases (sequentially during clinical practice) nor controls (sequen-
tially during clinical practice in the UK or via care centres in the Czech
Republic) is optimal. Study 1.2 involves subjects from two countries,
where either the bone structure of the subjects themselves, the CT scan-
ning technology or calibration differences could introduce systematic
errors. To counter this, we modelled study site in all the general linear
models. However, when examined on its own, it was clear that there
was a systematic difference between values of cortical and trabecular
bone between the UK and the Czech Republic. Furthermore, the inci-
dence of hip fracture as well as bone density values differ between
Czech Republic and the UK [55]. We suspect that the difference in cali-
bration phantoms (the 5 compartment Mindways K2HPO4 phantom
versus the 2 compartment Siemens Osteophantom) may also underlie
the systematic difference in CMSD and aBMD that we observed. An ad-
ditional limitation lies in the fact that the cases and controls from the
Czech Republic that we include in the combined analysis here have al-
ready been analysed - justified in order to achieve sufficient types of
hip fracture, but not optimal. The height and weight measurements
were not immediately pre-fracture, being either performed after frac-
ture repair or taken from past GP records. Matching was not achieved
in an optimal fashion and application of our results to the general pop-
ulation is not possible from such a sampling method. One subtlety
emerges from understanding the potential effects of correlated regres-
sors in SPM, regarding the need to leave out shapemode 1 (overall bone size)
and height in the model. This means that the reader must bear in mind that
some of the variance in CMSD or ECTD that we show as explained by group
(in Fig. 3) might be partly explained by subject height or femur size, since it is
well established(andalsoobserved in this study) that largerbonesaremoresus-
ceptible to fracture [11,56].Hence apriority is to test 3Dbonemappingmethods
in a studywhere samplinghas beenperformed appropriately, involvingwomen
whohave been followedprospectively for incident hip fracture. Therewere also
limitations to the biopsy study; it being performed on a small group of subjects
containing a mixture of female andmale subjects. While we can use microCT
to measure structural parameters, the more traditional technique of
histomorphometrymayilluminatetheremodellingmechanismsforthis focalos-
teoporosis and, for instance, whether fatigue or disuse underpin these focal
changes.
5. Conclusions
Women who sustain a hip fracture have focal osteoporosis in the
proximal femur. Femoral neck and trochanteric hip fractures involve
distinct patterns of focal osteoporosis. These findings support the
Table 1
Key protocol details for FEMCO Study (LREC07/H0305/61).
Protocol title, REC
number, REC committee
Regional thinning of the FEMoral neck COrtex in hip
fracture; a case-control study LREC07/H0305/61
ARC17822 v3.6 Cambridge Research Ethics
Committee 4
Objective To evaluate a novel index of bone fragility (regional
cortical thickness) using clinical quantitative computed
tomography (QCT) scanning of the proximal femur
Study design Case control study, convenience sampling for cases
and controls
Setting Multicentre, UK (Cambridge, Norwich, Torbay).
Initiated in 2007
Participants Eligibility- inclusion criteria. Cases Patients with first
hip fracture (femoral neck or trochanteric) awaiting
surgical fixation, not due for surgery within 4 h of
consent, able to understand, ask questions and give
witnessed consent (verbal or written), medically
stabilised. Controls Patients with a recent admission
to orthogeriatric unit following fall from standing
height or less, not sustaining hip fracture.
Exclusion criteria- Dementia/cognitive impairment
(AMTS b 7/10 or MMSE b19/30), unconsciousness,
terminal illness, metastatic cancer, previous hip
replacement (synthetic material at either hip),
previous hip fracture, osteomyelitis, bone tumour,
currently taking oral corticosteroids, prior
hemiplegia, prior treatment with teriparatide or
strontium ranelate
Matching criteria Convenience sample of cases. Convenience sample of
fallers, not matched beyond sex, minimum age and
injurious fall.
Scan protocol Patient Positioning for Hip QCT Supine on Siemens
Somatom Sensation 16, 64 or GE Lightspeed 64
scanner. Mindways 5-compartment solid phantom
positioned under the hips (calibrated to aqueous
K2HPO4 density), or phantom-free (using ClinicQCT
asynchronous calibration) if phantom previously
calibrated on that machine.
Acquisition parameters: scout view from iliac crest to
lesser trochanters. 120 kV, Tube current target
160mAS with Siemens CARE dosing, GE target dosing
up to 320mAS.
Reconstruction: To capture both hips and the phantom in
each reconstruction
1 mm slice thickness (0.5 mm increment) on Siemens
or 1.25 mm (0.625 increment) on GE 64. DFOV
400 mm (512*512 pixel matrix) = pixel size
0.5859 mm. Siemens B20f convolution kernel, GE
‘bone’ kernel. CT DICOM format images.
Fracture classification: a consultant radiologist (TDT)
reconstructed CT images with a multiplanar reformat
(MPR) and classified the fracture as subcapital,
transcervical or trochanteric using the Muller AO
classification, based on the anterior extent of the
fracture line.
Image processing: QCT PRO CTXA software (v5.1.3) -
reconstruct 3D image, analyse each hip for vBMD,
aBMD. Segmentation of contralateral hip in fracture
patients (Stradwin v 4.0) or both hips in control
patients followed by Bone Mapping.
Participants used for
present analysis (n)
Study 1.1 Hip fracture cases 50 females (37 femoral
neck, 13 trochanteric)
Study 1.1 Hip fracture cases 20 males (14 femoral
neck, 6 trochanteric)
Study 1.2 Hip fracture cases 60 females (46 femoral
neck, 14 trochanteric)
Study 1.3 Frail fallers 50 females
Demographics Fall description, site of impact, other injuries,
admitted from home/institution, MUST category
(malnutrition index), weight, last recorded height
(either GP record or measured), FRAX questions, pre
admission Barthel Index and Functional Ambulatory
Category, bone active medications, EPOS hip
questionnaire.
Bone density analysis aBMD of the femoral neck and total hip region region
using traditional ROIs specified in CTXA software
(QCTpro v 5.1.3).
Table 2
Key protocol details for Anglo-Cardiff Collaborative Trial (LREC 04/Q0108/257).
Protocol title, REC
number, REC committee
Isolated systolic hypertension, arterial stiffening and
calcification
LREC04/Q0108/257 Cambridge Research Ethics
Committee 4.
Objective To compare arterial stiffening with bone density in
healthy subjects using clinical quantitative computed
tomography (QCT) scanning of the proximal femur
Study design Case Control study, at random from local general
practice lists by letter of invitation (the overall
response rate was 85%).
Setting Multicentre, UK (Cambridge and Cardiff) Initiated in
2005
Participants Eligibility- Inclusion criteria. Controls Healthy males
not taking any medication able to understand, ask
questions and give witnessed consent (verbal or
written), medically stabilised.
Exclusion criteria- Diabetes mellitus,
hypercholesterolemia (self-reported or total
cholesterol ≥6.5 mmol/L), renal disease (defined as a
clinical history, creatinine ≥150 umol/L, or an active
urinary sediment), a history of cardio- vascular
disease (defined as a clinical history or evidence on
examination), known inflammatory conditions,
malignancy, or a recent history of infection,
dementia/cognitive impairment (AMTS b 7/10 or
MMSE b19/30), unconsciousness, terminal illness,
metastatic cancer, previous hip replacement
(synthetic material at either hip), previous hip
fracture, osteomyelitis, bone tumour.
Matching criteria Not matched beyond sex and minimum age.
Scan protocol Patient Positioning for Hip QCT Supine on Siemens
Somatom Sensation 16 scanner. Mindways
5-compartment solid phantom positioned under the
hips (calibrated to aqueous K2HPO4 density)
Acquisition parameters: Scout view from iliac crest to
lesser trochanters. 120 kV, Tube current target
160mAS with Siemens CARE dosing
Reconstruction: To capture both hips and the
phantom in each reconstruction
1 mm slice thickness (0.5 mm increment) on Siemens
DFOV 400 mm (512 ∗ 512 pixel matrix) = pixel size
0.5859 mm. Siemens B20f convolution kernel. CT
DICOM format images.
Image Processing: QCT PRO CTXA software (v5.1.3) -
Reconstruct 3D image, analyse each hip for vBMD,
aBMD. Segmentation of contralateral hip in fracture
patients (Stradwin v 4.0) or both hips in control
patients followed by Bone Mapping.
Participants used for
present analysis (n)
Study 1.2 Healthy controls 20
Demographics Weight, last recorded height (either GP record or
measured).
Bone density analysis aBMD of the femoral neck and total hip region region
using traditional ROIs specified in CTXA software
(QCTpro v 5.1.3).
131K.E.S. Poole et al. / Bone 94 (2017) 124–134hypothesis that focal osteoporotic defects play a key role in determining
fracture risk and fracture location. This information may assist in ana-
tomical targeting of future anti-fracture therapies applied locally
through minimally invasive surgery to vulnerable regions of the proxi-
mal femur.
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cational fora for Amgen and Lilly, he has been an advisory board mem-
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Table 3
Key protocol details for Cambridge MRC-Ageing study (LREC 06/Q0108/180).
Protocol title, REC
number, REC committee
Cortical thinning measured in vivo: determinant Of
hip fracture risk MRC LREC 06/Q0108/180 G0501550
version 1.0. Cambridge Research Ethics Committee
Objective To determine how accurately cortical thickness in the
femoral neck can be measured in vivo with the
purpose of determining changes with age and
whether this approach increases the ability to detect
those at increased risk of hip fracture
Study design Observational study of ageing, convenience sampling
for participants
Setting Single centre, Cambridge UK. Recruitment started in
2003
Participants Eligibility - inclusion criteria. Female, age over 20,
healthy volunteers attending Addenbrooke's NHS
Trust for a routine clinical CT scan which includes the
abdomen and pelvis
Exclusion criteria- Dementia/cognitive impairment,
unconsciousness, terminal illness, metastatic cancer,
previous hip replacement (synthetic material at
either hip), previous hip fracture, osteomyelitis, bone
tumour, known history of metabolic bone disease,
those taking oral corticosteroids, women already
enrolled in a study involving X-rays.
Participants used for
present analysis (n)
Study 1.2 and 1.3 Healthy controls 32
Scan protocol See FEMCO study. Not using GE Lightspeed scanner.
Further details in journal article [24]
Bone density analysis aBMD of the femoral neck and total hip region region
using traditional ROIs specified in CTXA software
(QCTpro v 5.1.3).
Table 5
Key protocol details for Prague Study of Hip Joint in Trauma study.
Protocol title, REC
number, REC committee
Study of Hip Joint in Trauma IRB0002384101 (Ethical
Committee of the Institute of Rheumatology and
Ethical Committee of Bulovka Hospital). FEMCO
amendment (approved by Cambridgeshire LREC4)
Objective To measure bone density by QCT in the femoral head
of fracture cases compared with age matched
controls.
Study design Case Control study, convenience sampling for cases
and controls
Setting Single centre, Prague, Czech Republic. Recruitment
started in 2006
Participants Eligibility- inclusion criteria. Cases Female with first
hip fracture (femoral neck or trochanteric) attending
Bulovka University Hospital Prague, awaiting surgical
fixation, able to give informed consent, low energy
injury. Controls healthy volunteers by invitation at
rheumatology clinics and two residential care centres
in the same districts of Prague, attending Homolka
Hospital Prague.
Exclusion criteria- terminal illness, metastatic cancer,
previous hip replacement (synthetic material at
either hip), subtrochanteric fracture, known history
of unilateral bone disease.
Participants used for
present analysis (n)
Study 1.2 Hip fracture cases 78 (40 femoral neck 38
trochanteric)
Study 1.2 Control fallers 75
Scan protocol Patient Positioning for Hip QCT Supine on Siemens
Somatom Sensation 16 or 40 scanner. Siemens
two-compartment Osteo phantom.
Reconstruction: To capture both hips and the
phantom in each reconstruction. Siemens B10/B20s
convolution kernel, ≤1 mm reconstructed slice
thickness CT DICOM format images.
Fracture classification: A consultant radiologist (TDT)
reconstructed CT images with a multiplanar reformat
(MPR) and classified the fracture as subcapital,
transcervical or trochanteric using the Muller AO
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search grant support from Amgen Inc. and Lilly. AHG has receivedTable 4
Key protocol details for Cambridge MRC-Hip Fx study (LREC 99/076).
Protocol title, REC
number, REC committee
Measurement of femoral neck bone loss in cases of
hip fracture compared to hospital controls MRC
LREC99/076 version 1.0. Cambridge Research Ethics
Committee
Objective To estimate cortical bone stability in the contralateral
hip of fracture cases compared with measurements of
age matched controls
Study design Case Control study, convenience sampling for cases
and controls
Setting Single centre, Cambridge, UK. Recruitment started in
2001
Participants Eligibility - inclusion criteria. Cases Female with first
hip fracture (femoral neck or trochanteric) post
surgical fixation, able to understand, ask questions
and give witnessed consent, medically stabilised.
Controls healthy volunteers attending Addenbrooke's
NHS Trust for a routine clinical CT scan which
includes the abdomen and pelvis, who were
subsequently found to have no carcinoma.
Exclusion criteria- Dementia/cognitive impairment,
unconsciousness, terminal illness, metastatic cancer,
previous hip replacement (synthetic material at
either hip), previous hip fracture, osteomyelitis, bone
tumour, known history of metabolic bone disease,
those taking oral corticosteroids, women already
enrolled in a study involving x-rays.
Participants used for
present analysis (n)
Study 1.2 and 1.3 healthy controls 18
Scan protocol See FEMCO study. Not using GE Lightspeed scanner
Bone density analysis aBMD of the femoral neck and total hip region region
using traditional ROIs specified in CTXA software
(QCTpro v 5.1.3)
classification, based on the anterior extent of the
fracture line.
Image Processing: QCT PRO CTXA software (v5.1.3)-
Reconstruct 3D image, analyse each hip for vBMD,
aBMD. Segmentation of contralateral hip in fracture
patients (Stradwin v 4.0) or both hips in control
patients followed by Bone Mapping.
Further details in journal article [6]
Bone density analysis aBMD of the femoral neck and total hip region region
using traditional ROIs specified in CTXA software
(QCTpro v 5.1.3).research grant support from Amgen Inc. and Lilly. TDT has lectured in
educational fora for Amgen.
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